LWAC
BMY icon

Laurel Wealth Advisors (California)’s Bristol-Myers Squibb BMY Stock Holding History

Laurel Wealth Advisors (California)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.1M Sell
15,230
-26
-0.2% -$1.96K 0.11% 200
2022
Q3 		$1.08M Buy
15,256
+19
+0.1% +$1.38K 0.12% 198
2022
Q2 		$1.17M Sell
15,237
-355
-2% -$27K 0.12% 192
2022
Q1 		$1.14M Sell
15,592
-375
-2% -$25.2K 0.09% 224
2021
Q4 		$996K Buy
15,967
+4,994
+46% +$293K 0.08% 257
2021
Q3 		$649K Sell
10,973
-167
-1% -$11K 0.12% 200
2021
Q2 		$745K Buy
11,140
+14
+0.1% +$913 0.1% 212
2021
Q1 		$702K Sell
11,126
-639
-5% -$39.8K 0.11% 199
2020
Q4 		$730K Sell
11,765
-58
-0.5% -$3.57K 0.11% 187
2020
Q3 		$712K Sell
11,823
-18
-0.2% -$1.08K 0.12% 184
2020
Q2 		$696K Sell
11,841
-35
-0.3% -$2.09K 0.13% 173
2020
Q1 		$662K Sell
11,876
-30
-0.3% -$1.83K 0.15% 161
2019
Q4 		$765K Sell
11,906
-5,598
-32% -$321K 0.13% 188
2019
Q3 		$887K Buy
17,504
+8,263
+89% +$388K 0.15% 164
2019
Q2 		$419K Buy
9,241
+1,439
+18% +$67K 0.09% 243
2019
Q1 		$372K Buy
7,802
+166
+2% +$8.27K 0.09% 250
2018
Q4 		$396K Sell
7,636
-824
-10% -$44.3K 0.12% 200
2018
Q3 		$525K Buy
8,460
+266
+3% +$15.8K 0.13% 183
2018
Q2 		$453K Buy
8,194
+240
+3% +$13K 0.12% 193
2018
Q1 		$503K Buy
7,954
+745
+10% +$47.9K 0.16% 158
2017
Q4 		$441K Buy
7,209
+891
+14% +$55.7K 0.13% 186
2017
Q3 		$402K Buy
6,318
+4
+0.1% +$234 0.13% 177
2017
Q2 		$351K Buy
6,314
+418
+7% +$22.7K 0.12% 189
2017
Q1 		$320K Sell
5,896
-662
-10% -$36.3K 0.12% 188
2016
Q4 		$383K Sell
6,558
-1,257
-16% -$68.7K 0.17% 152
2016
Q3 		$421K Buy
7,815
+235
+3% +$15.1K 0.2% 133
2016
Q2 		$558K Buy
7,580
+1,010
+15% +$71.4K 0.27% 99
2016
Q1 		$420K Sell
6,570
-921
-12% -$58.1K 0.21% 125
2015
Q4 		$515K Buy
+7,491
New +$495K 0.27% 105

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Laurel Wealth Advisors (California)'s BMY Position: Q4 2022 in Review

Laurel Wealth Advisors (California) reduced its Bristol-Myers Squibb (BMY) stake by 0.17% in Q4 2022, selling an estimated $1.96K and leaving 15,230 shares worth $1.1M. The position accounts for 0.11% of the portfolio, ranked #200.

Laurel Wealth Advisors (California) first reported a position in BMY in Q4 2015 and has held it in 29 quarters since. The position peaked at $1.17M in Q2 2022. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

  • Laurel Wealth Advisors (California) held 15,230 shares of Bristol-Myers Squibb worth $1.1M as of Q4 2022.
  • Laurel Wealth Advisors (California) sold 26 Bristol-Myers Squibb shares in Q4 2022, an estimated $1.96K.
  • Bristol-Myers Squibb made up 0.11% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #200 holding.
  • Laurel Wealth Advisors (California) first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 29 quarters since.
  • Laurel Wealth Advisors (California)'s Bristol-Myers Squibb position peaked at $1.17M in Q2 2022.
  • 2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.